PRKAA1 and mitochondrial disease: The efficacy of AMPK agonists including metformin, resveratrol and 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) for treating mitochondrial disease has been explored with limited success and conflicting results [17–19].